Fidelity Investments
VIR icon

Fidelity Investments’s Vir Biotechnology VIR Stock Holding History

Fidelity Investments’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.6M Buy
2,318,294
+246,446
+12% +$2.34M ﹤0.01% 1822
2026
Q1 		$18.6M Sell
2,071,848
-1,086,568
-34% -$8.66M ﹤0.01% 1811
2025
Q4 		$19M Sell
3,158,416
-478,714
-13% -$2.85M ﹤0.01% 1795
2025
Q3 		$20.8M Buy
3,637,130
+78,475
+2% +$401K ﹤0.01% 1743
2025
Q2 		$17.9M Buy
3,558,655
+1,342,221
+61% +$7.2M ﹤0.01% 1727
2025
Q1 		$14.4M Buy
2,216,434
+2,209,318
+31,047% +$19.6M ﹤0.01% 1791
2024
Q4 		$52.2K Buy
7,116
+5,882
+477% +$46.4K ﹤0.01% 3834
2024
Q3 		$9.24K Sell
1,234
-6,799
-85% -$59.1K ﹤0.01% 4449
2024
Q2 		$71.5K Buy
8,033
+1,327
+20% +$12.7K ﹤0.01% 3446
2024
Q1 		$67.9K Buy
6,706
+333
+5% +$3.39K ﹤0.01% 3446
2023
Q4 		$64.1K Sell
6,373
-147,289
-96% -$1.35M ﹤0.01% 3409
2023
Q3 		$1.44M Sell
153,662
-106,134
-41% -$1.51M ﹤0.01% 2374
2023
Q2 		$6.37M Buy
259,796
+127,018
+96% +$3.19M ﹤0.01% 1994
2023
Q1 		$3.09M Buy
132,778
+62,328
+88% +$1.59M ﹤0.01% 2246
2022
Q4 		$1.78M Buy
70,450
+23,010
+49% +$564K ﹤0.01% 2410
2022
Q3 		$914K Buy
47,440
+13,245
+39% +$337K ﹤0.01% 2631
2022
Q2 		$870K Buy
34,195
+2,063
+6% +$48.2K ﹤0.01% 2715
2022
Q1 		$826K Sell
32,132
-251,514
-89% -$7.46M ﹤0.01% 2829
2021
Q4 		$11.9M Buy
+283,646
New +$11.1M ﹤0.01% 2044
2021
Q3 		– Sell
-1
Closed – – 5087
2021
Q2 		$0 Buy
+1
New +$45 ﹤0.01% 4928
2021
Q1 		– Sell
-6
Closed -$323 – 4573
2020
Q4 		$0 Buy
+6
New +$195 ﹤0.01% 4313

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fidelity Investments's VIR Position: Q2 2026 in Review

Fidelity Investments increased its Vir Biotechnology (VIR) stake by 12% in Q2 2026, buying an estimated $2.34M and bringing the position to 2,318,294 shares worth $23.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1822.

Fidelity Investments first reported a position in VIR in Q4 2020 and has held it in 21 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Fidelity Investments held 2,318,294 shares of Vir Biotechnology worth $23.6M as of Q2 2026.
  • Fidelity Investments bought 246,446 Vir Biotechnology shares in Q2 2026, an estimated $2.34M.
  • Vir Biotechnology made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #1822 holding.
  • Fidelity Investments first reported a position in Vir Biotechnology in Q4 2020 and has held it in 21 quarters since.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.